Healthcare Global Enterprises Q3 Results 2025:Healthcare Global Enterprises declared their Q3 results on 14 Feb, 2025. The topline increased by 18.89% & the profit increased by 22.46% YoY. Profit at ₹6.98 crore and revenue at ₹557.55 crore.
As compared to the previous quarter, the revenue grew by 0.92% while the profit decreased by 61.2%. The Selling, general & administrative expenses rose by 5.83% q-o-q and increased by 16.69% Y-o-Y.
The operating income was down by 40.07% q-o-q and decreased by 8.05% Y-o-Y. The EPS is ₹0.49 for Q3 which increased by 19.51% Y-o-Y.
Healthcare Global Enterprises has delivered -6.66% return in the last 1 week, 37.49% return in last 6 months and 0.06% YTD return.
Currently, the Healthcare Global Enterprises has a market cap of ₹6823.1 Cr and a 52-week high/low of ₹567.7 & ₹314 respectively.
As of 16 Feb, 2025, out of 5 analysts covering the company, 4 analysts have given a Buy rating and 1 analyst has given a Strong Buy rating. The consensus recommendation as on 16 Feb, 2025 was to Buy.
Healthcare Global Enterprises Financials
Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 557.55 | 552.47 | +0.92% | 468.95 | +18.89% |
Selling/ General/ Admin Expenses Total | 90.24 | 85.27 | +5.83% | 77.33 | +16.69% |
Depreciation/ Amortization | 56.52 | 49.74 | +13.63% | 44.16 | +27.99% |
Total Operating Expense | 526.71 | 501.01 | +5.13% | 435.41 | +20.97% |
Operating Income | 30.84 | 51.46 | -40.07% | 33.54 | -8.05% |
Net Income Before Taxes | -3.3 | 27.65 | -111.93% | 11.06 | -129.84% |
Net Income | 6.98 | 17.99 | -61.2% | 5.7 | +22.46% |
Diluted Normalized EPS | 0.49 | 1.28 | -61.72% | 0.41 | +19.51% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.